Stero Biotechs Ltd.

Quick facts

Marketed products

• CBD · Neurology, Psychiatry, Pain Management, Immunology
  CBD (cannabidiol) modulates endocannabinoid signaling and interacts with multiple receptors including serotonin 5-HT1A, TRPV1, and GPR55 to produce anti-inflammatory, anxiolytic, and analgesic effects.

Phase 2 pipeline

• Cannabidiol , synthetic form

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Stero Biotechs Ltd. portfolio CI brief
• Stero Biotechs Ltd. pipeline updates RSS